Internal Medicine, Hematology & Oncology · Gold Beach, OR
NPI
1104245190
Since 2014
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
2
Medicare group memberships
Hospitals
0
Hospital affiliations
94220 4th St
Gold Beach, OR, 97444
Phone (541) 247-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$11K
866 services
Medicare patients, 2024
11
Average age 63
Drug cost, 2024
$5.3M
2,400 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Matthew Tipping prescribed most often to Medicare patients was Anastrozole, with 528 prescriptions and refills. In total Matthew Tipping wrote 2,400 Medicare prescriptions that cost $5.3M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-09-21.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Anastrozole Generic | 528 | 1,498 | 159 | $14K |
| Abiraterone Acetate Generic | 198 | 407 | 53 | $60K |
| Prednisone Generic | 193 | 438 | 63 | $1,596 |
| Xtandi Enzalutamide | 141 | 141 | 19 | $1.6M |
| Letrozole Generic | 126 | 335 | 43 | $2,351 |
| Ondansetron Hcl Generic | 104 | 107 | 48 | $823 |
| Ibrance Palbociclib | 100 | 100 | 11 | $1.5M |
| Exemestane Generic | 91 | 264 | 34 | $7,207 |
| Prochlorperazine Maleate Generic | 83 | 83 | 44 | $1,049 |
| Alendronate Sodium Generic | 78 | 215 | 24 | $761 |
| Dexamethasone Generic | 74 | 97 | 39 | $1,183 |
| Tamoxifen Citrate Generic | 72 | 209 | 26 | $1,783 |
| Kisqali Ribociclib Succinate | 67 | 67 | 12 | $1.0M |
| Xarelto Rivaroxaban | 45 | 78 | Under 11 | $35K |
| Potassium Chloride Generic | 41 | 67 | 15 | $693 |
Brand drugs: 457 claims; generic drugs: 1,943 claims; opioid claims: 47.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Matthew Tipping were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.